Copyright
©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 111309
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.111309
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.111309
Table 1 Risk factors for gestational diabetes mellitus
| Risk factors |
| Overweight or obese adults (BMI ≥ 25 kg/m2, ≥ 23 kg/m2 for Asians) with at least one of the following risk factors: |
| History of diabetes in a first-degree relative |
| High-risk race or ethnicity (e.g., African American, Latin American) |
| History of cardiovascular disease |
| HDL cholesterol level < 35 mg/dL (< 0.9 mmol/L) and/or triglyceride level > 250 mg/dL (> 2.8 mmol/L) |
| Polycystic ovary syndrome |
| Physical inactivity |
| Other clinical conditions associated with insulin resistance (obesity, acanthosis nigricans) |
| Prediabetes (HbA1c ≥ 5.7%) and impaired fasting and glucose tolerance |
| Individuals previously diagnosed with GDM |
| Individuals afflicted with HIV, those utilizing medications that elevate the risk of diabetes, and those with a history of pancreatitis. Additionally, ACOG: |
| History of birth over 4000 g |
| Hypertension (140/90 mmHg or those taking antihypertensive medication) |
Table 2 Maternal and fetal complications of gestational diabetes mellitus
| Maternal | Fetal | |
| Short term | Preeclampsia | Macrosomia |
| Preterm delivery | Shoulder dystocia | |
| Caesarean section | Perinatal mortality | |
| Failure to progress in labour and instrumental delivery | Admission to NICU | |
| Neonatal hypoglycaemia | ||
| Hyperbilirubinaemia | ||
| Long term | Recurrent GDM in subsequent pregnancies | Type 2 diabetes |
| Type 2 diabetes | Obesity | |
| Cardiovascular disease |
Table 3 Screening and diagnosis of gestational diabetes mellitus
| One-step strategy | Two-step strategy | |
| Test | 75 g OGTT: In individuals without a prior diagnosis of diabetes, screening is performed in the fasting state between 24 and 28 weeks of gestation (following a minimum of 8 hours of overnight fasting). GDM is diagnosed if any of the following blood glucose thresholds are met or exceeded | First step: 50 g glucose challenge test: This test is administered between 24 and 28 weeks of gestation in individuals without a prior diagnosis of diabetes and does not require fasting. If the 1-hour plasma glucose level meets or exceeds the specified threshold values, a 100 g OGTT should be performed |
| Blood glucose thresholds | IADPSG: Fasting glucose ≥ 93 mg/dL (≥ 5.1 mmol/L) | Fasting glucose ≥ 95 mg/dL (≥ 5.3 mmol/L) |
| 1-hour plasma glucose ≥ 180 mg/dL (≥ 10.0 mmol/L) | 1-hour plasma glucose ≥ 180 mg/dL (≥ 10.0 mmol/L) | |
| 2-hour plasma glucose ≥ 153 mg/dL (≥ 8.5 mmol/L) | 2-hour plasma glucose ≥ 155 mg/dL (≥ 8.6 mmol/L) | |
| Carpenter-Coustan criteria: Fasting glucose ≥ 95 mg/dL (≥ 5.3 mmol/L) | 2-hour plasma glucose ≥ 140 mg/dL (≥ 7.8 mmol/L) | |
| 1-hour plasma glucose ≥ 180 mg/dL (≥ 10.0 mmol/L) | ||
| 2-hour plasma glucose ≥ 155 mg/dL (≥ 8.6 mmol/L) |
Table 4 Gestational diabetes mellitus screening strategies recommended by various international organizations
| Guide | Strategy |
| ADA | 75 g OGTT for all pregnant women |
| ACOG | Administer a 50 g GCT for all pregnant women; a 100 g OGTT is required if the initial test is positive |
| WHO | 75 g OGTT for all pregnant women |
| NICE | 75 g OGTT risk-based approach |
| FIGO | 75 g OGTT for all pregnant women |
- Citation: Kaymak D, Ozgu-Erdinc AS. Advances in gestational diabetes mellitus screening: Emerging trends and future directions. World J Diabetes 2025; 16(10): 111309
- URL: https://www.wjgnet.com/1948-9358/full/v16/i10/111309.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i10.111309
